Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine. According to clinical and histopathological findings, considering the temporal relationship with vaccine administration, we diagnosed her with nail psoriasis associated with Pfizer/ ...
The search for articles was carried out in the Pubmed/Medline, SciELO, Cochrane Library and LILACS databases, using the following descriptors: Psoriasis; Exacerbation; COVID-19; Vaccination; Psoriasis; Exacerbation; COVID-19; Vaccine. The search was restricted to articles published from 2019 to ...
A 46﹜ear﹐ld Caucasian male presented with psoriasis flare up, which occurred a day after second dose of COVID Pfizer〣ioNTech BNT16B2b2 mRNA vaccine. The patient had been suffering from plaque psoriasis for 24 years. During the last 21 months his psoriasis was completely clear (PASI 0 poi...
Also, at about the same time as the exacerbation of the eruption, there were adverse reactions due to the COVID19 vaccine. From these viewpoints, we considered that the rash exacerbation in our patient was not due to the diminished effect of risankizumab, and was an effect of the vaccine...
In terms of vaccine types, Pfizer is the most commonly reported (49 cases; 67.1%), followed by Astra-Zeneca (13 cases; 17.8%), Moderna (10 cases; 13.7%), and CoronaVac (1 case; 1.4%). The onset of psoriasis after receiving the COVID-19 Vaccines was varied, ranging from 1 to 90 ...
mRNA vaccines, including those produced by Moderna and BioNTech/Pfizer, were frequently associated with subsequent psoriasis episodes. First, second, and third vaccine doses were associated with psoriasis incidents, with the second dose most frequently associated with psoriasis flares. Delayed onset was ...
This article presents a case study of a 65-year-old man who developed generalized pustular psoriasis (GPP) and acute respiratory distress syndrome (ARDS) after receiving the second dose of the BioNTech/Pfizer COVID-19 vaccine. The patient experienced pruritic erythema three days after vaccination,...
Commentary on 'Psoriasis flare-up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine'.doi:10.1111/jdv.18117D.TurkmenDepartment of Dermatology, Inonu University, Malatya, Turkey.N.AltunisikDepartment of Dermatology, Inonu University, Malatya, Turkey.Journal of the ...
and assessed the COVID-19 vaccine-induced plaque psoriasis in terms of clinical presentation, post-vaccination flare period and treatment status, as well as inner exposome parameters (genomics, oxidative stress, hormonal impact due to gender, aging, skin color) and external parameters (UV, infectom...
psoriasis have been reported following vaccination, all of the cases have been successfully treated while overall benefit–risk profile of COVID-19 vaccination does not justify vaccine hesitancy due to the risk of psoriasis being developed or worsening. Certainly, further studies are needed to ...